PLUVICTO
Live / Registered — Registered (as of 02 Aug 2022)
What this means for you
Registered since 02 Aug 2022. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 88758613
- Registration number
- 6809402
- Mark type
- Stylized text
- Filed
- 14 Jan 2020
- Published for opposition
- 05 May 2020
- Registered
- 02 Aug 2022
- Attorney of record
- Maury M. Tepper, III
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the diagnosis and treatment of oncological diseases and disorders; pharmaceutical preparations for the purpose of increasing the effectiveness of other pharmaceutical products in the treatment of oncological diseases; drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals to treat cancer
Owner
- NOVARTIS AG, BASEL, CH
- ENDOCYTE, INC., West Lafayette, IN, US
- ENDOCYTE, INC., West Lafayette, IN, US
- ENDOCYTE, INC., West Lafayette, IN, US
Prosecution history
- 07 Sept 2022 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 02 Aug 2022 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 02 Aug 2022 — REGISTERED-PRINCIPAL REGISTER
- 28 Jun 2022 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 25 Jun 2022 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 13 Jun 2022 — STATEMENT OF USE PROCESSING COMPLETE
- 25 May 2022 — USE AMENDMENT FILED
- 13 Jun 2022 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 25 May 2022 — TEAS STATEMENT OF USE RECEIVED
- 30 Dec 2021 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 28 Dec 2021 — SOU EXTENSION 3 GRANTED
- 28 Dec 2021 — SOU EXTENSION 3 FILED
- 28 Dec 2021 — SOU TEAS EXTENSION RECEIVED
- 22 Jun 2021 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 18 Jun 2021 — SOU EXTENSION 2 GRANTED